Scientists at the National University of Singapore have published an atomic-level structure of the prion-like C-terminus of TDP-43, a protein associated with several neurodegenerative disorders. Their results confirm a highly disordered domain—similar to that of other RNA-binding proteins—that readily forms reversible oligomers. It is thought that this oligomerization helps organize RNA granules, which dynamically form and disperse in cells to control the translation of RNA.
Led by Jianxing Song, the researchers report that disease-related point mutations in this region of TDP-43 make the protein more likely to amass into amyloids or insoluble aggregates. Curiously, they identify a helical subdomain that interacts with membranes. They hypothesize that this association contributes to neurotoxicity and triggers amyotrophic lateral sclerosis (ALS). The results were published January 6 in PLoS Biology.
“It’s the first structural characterization of the whole prion-like domain of TDP-43, and the first study to look at the molecular effects of its disease-linked mutations,” said Nicolas Fawzi, Brown University, Providence, R.I., who was not involved in the research. He was curious whether the other 46 ALS-linked mutations identified in this region work by the same mechanism. He and colleagues had previously published the atomic structure of another prion-like domain of an RNA-binding protein, fused in sarcoma (FUS), and found a similarly disordered protein segment (Burke et al., 2015; Oct 2015 Webinar).
TDP-43 is a DNA- and RNA-binding protein that tends to misfold. Aggregates of the protein accumulate in neurons in patients with ALS, frontotemporal dementia, and Alzheimer’s disease. Its penchant for aggregation has complicated studies of its structure and physiological function. However, by using ultra-pure, salt-free water as a solvent, Song and colleagues kept this normally insoluble protein from binding to itself. He then resolved its native conformation. He had previously used the same strategy to solve the atomic-level structures of the ALS-linked proteins SOD1 and VAPB (Li et al., 2006; Lim et al., 2015; Qin et al, 2013). Most recently, he resolved the amino stub of TDP-43 (Dec 2014 news).
In the current study, first author Liangzhong Lim used a combination of circular dichroism (CD), fluorescence spectroscopy, nuclear magnetic resonance (NMR) spectroscopy, and electron miscopy to decode the minute details of the opposite end of the protein. The C-terminal region of TDP-43 is packed with the amino acids glutamine, asparagine, serine, and glycine, and has been blamed for the prion-like spread of ALS (for a review, see Polymenidou and Cleveland, 2011). This part of the protein also contains most of the known pathogenic mutations. To see how those polymorphisms affect this prion-like domain, the researchers compared the wild-type version with that of three ALS-linked mutants—A315E, Q331K, and M337V.
Lim and colleagues found the domain intrinsically disordered, lacking any fixed three-dimensional structure. It hangs loose and readily assembles into β-sheet-rich oligomers. While point mutations leave the overall structure mostly unchanged, they vary the peptide just enough so that it rapaciously assembles into amyloids. The results fit with studies reporting that mutations in the same regions of other DNA-binding proteins, such as FUS, make them more prone to aggregate (Murakami et al. 2015).
Previous reports suggest that prion-like domains in TDP-43 and FUS can bind nucleic acids (Han et al., 2012; Kato et al., 2012). Accordingly, Lim and colleagues found that single-stranded DNA enhanced oligomerization of wild-type TDP43 and aggregation of the mutant forms.
Curiously, the authors found that in the presence of an artificial phospholipid bilayer, the area between residues Met311 and Gln343 folded into a membrane-burrowing structure consisting of an Ω-shaped loop and an α-helix. While several ALS-linked mutations lie in this region, none of those tested altered this structure. However, these mutants assembled into aggregates faster than did other TDP43 variants. The authors suggest that the membrane-interacting subdomain helps concentrate the wild-type protein, favoring aggregation that may become toxic to cells.
“This interaction with the membrane is perhaps the most novel aspect of the work,” said Jim Shorter, University of Pennsylvania, Philadelphia. Song noted that other ALS-linked proteins, such as SOD1, acquire the ability to interact with the membrane and become toxic, and he suggested this might be a common mechanism for their cytotoxicity (Lim et al., 2014; Qin et al., 2013). However, Shorter and Fawzi noted that TDP-43 does not typically associate with the membrane and wondered if the interaction was physiological.
The results fit Shorter’s previous report that ALS-related mutations in the prion-like domain of TDP-43 promote aggregation in yeast (Johnson et al., 2009). If small molecules could make mutant forms of the protein less likely to aggregate, they may treat disorders such as ALS, Shorter speculated. He noted that Lim and colleagues looked only at an isolated portion of this protein; what happens in the context of full-length TDP-43 remains unclear.
Lim L, Wei Y, Lu Y, Song J. ALS-Causing Mutations Significantly Perturb the Self-Assembly and Interaction with Nucleic Acid of the Intrinsically Disordered Prion-Like Domain of TDP-43. PLoS Biol. 2016 Jan;14(1):e1002338. Epub 2016 Jan 6 [PubMed].
To view commentaries, primary articles and linked stories, go to the original posting on Alzforum.org here.
Copyright © 1996–2017 Biomedical Research Forum, LLC. All Rights Reserved.